ORCHESTRA BIOMED HOLDINGS IN (OBIO) Top Institutional Shareholders

ORCHESTRA BIOMED HOLDINGS IN (OBIO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $97.96M in OBIO holdings during the latest filing period.

Rtw Investments, Lp is currently the largest disclosed institutional shareholder of OBIO tracked by InsiderSet, reporting ownership valued at approximately $35.30M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $32.14M, representing an estimated loss of -8.94% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 87% of the total disclosed OBIO value among the investors covered in this analysis. Major shareholders include Rtw Investments, Lp, Perceptive Advisors Llc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in ORCHESTRA BIOMED HOLDINGS IN (OBIO).

This page ranks the largest institutional OBIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

64

Total Reported Value

$97.96M

Largest Holder

Rtw Investments, Lp

Largest Position

$35.30M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

81

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Rtw Investments, Lp0.35%8,306,063$35,300,768$32,144,464-$3,156,304-8.94%
Perceptive Advisors Llc0.42%5,037,906$21,411,101$19,496,696-$1,914,405-8.94%
Vanguard Capital Management Llc0.00%2,204,319$9,368,356$8,530,715-$837,641-8.94%
Alyeska Investment Group, L.P.0.01%1,000,000$4,250,000$3,870,000-$380,000-8.94%
Propel Bio Management, Llc2.41%896,701$3,830,724$3,470,233-$360,491-9.41%
Millennium Management Llc0.00%702,543$2,985,808$2,718,841-$266,967-8.94%
Blackrock, Inc.0.00%635,714$2,701,784$2,460,213-$241,571-8.94%
Geode Capital Management, Llc0.00%485,492$2,064,440$1,878,854-$185,586-8.99%
Affinity Asset Advisors, Llc0.10%402,550$1,710,838$1,557,869-$152,970-8.94%
Charles Schwab Investment Management Inc0.00%265,499$1,128,371$1,027,481-$100,890-8.94%
Knott David M Jr0.64%253,651$1,078,017$981,629-$96,388-8.94%
Vanguard Fiduciary Trust Co0.00%235,214$999,660$910,278-$89,382-8.94%
Simplify Asset Management Inc.0.01%219,387$932,395$849,028-$83,367-8.94%
Marshall Wace, Llp0.00%188,484$801,059$729,433-$71,626-8.94%
683 Capital Management, Llc0.07%185,000$786,250$715,950-$70,300-8.94%
State Street Corp0.00%169,410$719,993$655,617-$64,376-8.94%
Goldman Sachs Group Inc0.00%155,242$659,779$600,787-$58,992-8.94%
Dafna Capital Management Llc0.12%126,841$539,074$490,875-$48,199-8.94%
Northern Trust Corp0.00%118,274$502,665$457,720-$44,945-8.94%
Qube Research & Technologies Ltd0.00%108,953$463,050$421,648-$41,402-8.94%
Ifp Advisors, Inc0.01%98,887$420,270$382,693-$37,577-8.94%
Susquehanna International Group, Llp0.00%97,521$414,464$377,406-$37,058-8.94%
Point72 Asset Management, L.P.0.00%87,888$373,524$340,127-$33,397-8.94%
Citadel Advisors Llc0.00%79,185$336,536$306,446-$30,090-8.94%
Hudson Bay Capital Management Lp0.00%71,134$302,320$275,289-$27,031-8.94%
Renaissance Technologies LLCJim Simons0.00%70,900$301,325$274,383-$26,942-8.94%
Bridgeway Capital Management, Llc0.01%70,600$300,050$273,222-$26,828-8.94%
Two Sigma Investments, Lp0.00%60,107$255,455$232,614-$22,841-8.94%
Barclays Plc0.00%59,342$252,204$229,654-$22,550-8.94%
Jane Street Group, Llc0.00%55,680$236,640$215,482-$21,158-8.94%
Daytona Street Capital Llc0.18%52,600$235,443$203,562-$31,881-13.54%
Bank Of America Corp0.00%52,761$224,234$204,185-$20,049-8.94%
Holos Integrated Wealth Llc0.11%51,595$219,795$199,673-$20,122-9.16%
Ubs Group Ag0.00%50,310$213,818$194,700-$19,118-8.94%
Brevan Howard Capital Management Lp0.00%36,769$156,268$142,296-$13,972-8.94%
Morgan Stanley0.00%35,639$151,466$137,923-$13,543-8.94%
Meramec Financial Planners, Llc0.05%30,000$130,500$116,100-$14,400-11.03%
Catalyst Funds Management Pty Ltd0.02%27,644$117,487$106,982-$10,505-8.94%
Citigroup Inc0.00%25,529$108,498$98,797-$9,701-8.94%
Cannon Global Investment Management, Llc0.23%22,607$96,080$87,489-$8,591-8.94%
Rice Hall James & Associates, Llc0.00%19,001$80,754$73,534-$7,220-8.94%
Diametric Capital, Lp0.02%18,919$80,405$73,217-$7,188-8.94%
Hightower Advisors, Llc0.00%18,275$77,669$70,724-$6,945-8.94%
Fmr Llc0.00%18,076$76,824$69,954-$6,870-8.94%
Omers Administration Corp0.00%16,200$68,850$62,694-$6,156-8.94%
Vanguard Global Advisers, Llc0.00%13,948$59,279$53,979-$5,300-8.94%
Able Financial Group, Llc0.01%13,402$56,959$51,866-$5,093-8.94%
Frec Markets, Inc.0.01%13,048$55,454$50,496-$4,958-8.94%
Prelude Capital Management, Llc0.00%12,389$52,653$47,945-$4,708-8.94%
Canada Pension Plan Investment Board0.00%11,300$48,025$43,731-$4,294-8.94%

Frequently asked questions about OBIO

  • Who owns the most OBIO stock?

    The largest holders of OBIO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ORCHESTRA BIOMED HOLDINGS IN (OBIO).

  • Is OBIO widely held by superinvestors?

    Many widely followed stocks like OBIO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly OBIO is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.